Notice: This company has been marked as potentially delisted and may not be actively trading. Neuralstem (CUR) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CUR vs. FRTX, ONVO, CELZ, TTNP, GENE, SCNI, CERO, EVAX, PALI, and WINTShould you be buying Neuralstem stock or one of its competitors? The main competitors of Neuralstem include Fresh Tracks Therapeutics (FRTX), Organovo (ONVO), Creative Medical Technology (CELZ), Titan Pharmaceuticals (TTNP), Genetic Technologies (GENE), Scinai Immunotherapeutics (SCNI), CERo Therapeutics (CERO), Evaxion Biotech A/S (EVAX), Palisade Bio (PALI), and Windtree Therapeutics (WINT). These companies are all part of the "medical" sector. Neuralstem vs. Fresh Tracks Therapeutics Organovo Creative Medical Technology Titan Pharmaceuticals Genetic Technologies Scinai Immunotherapeutics CERo Therapeutics Evaxion Biotech A/S Palisade Bio Windtree Therapeutics Neuralstem (NASDAQ:CUR) and Fresh Tracks Therapeutics (NASDAQ:FRTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, community ranking, media sentiment, institutional ownership and valuation. Do insiders & institutionals have more ownership in CUR or FRTX? 38.3% of Neuralstem shares are held by institutional investors. Comparatively, 25.0% of Fresh Tracks Therapeutics shares are held by institutional investors. 5.4% of Neuralstem shares are held by insiders. Comparatively, 0.2% of Fresh Tracks Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, CUR or FRTX? Neuralstem has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500. Comparatively, Fresh Tracks Therapeutics has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Does the MarketBeat Community favor CUR or FRTX? Neuralstem received 278 more outperform votes than Fresh Tracks Therapeutics when rated by MarketBeat users. Likewise, 66.83% of users gave Neuralstem an outperform vote while only 0.00% of users gave Fresh Tracks Therapeutics an outperform vote. CompanyUnderperformOutperformNeuralstemOutperform Votes27866.83% Underperform Votes13833.17% Fresh Tracks TherapeuticsOutperform VotesNo VotesUnderperform Votes1100.00% Does the media prefer CUR or FRTX? In the previous week, Neuralstem's average media sentiment score of 0.00 equaled Fresh Tracks Therapeutics'average media sentiment score. Company Overall Sentiment Neuralstem Neutral Fresh Tracks Therapeutics Neutral Which has preferable earnings & valuation, CUR or FRTX? Neuralstem has higher earnings, but lower revenue than Fresh Tracks Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuralstem$260K5.50-$4.93MN/AN/AFresh Tracks Therapeutics$10.06M0.56-$5.69M-$1.41-0.66 Is CUR or FRTX more profitable? Fresh Tracks Therapeutics has a net margin of 0.00% compared to Neuralstem's net margin of -39,417.64%. Fresh Tracks Therapeutics' return on equity of 0.00% beat Neuralstem's return on equity.Company Net Margins Return on Equity Return on Assets Neuralstem-39,417.64% -170.51% -110.16% Fresh Tracks Therapeutics N/A N/A N/A SummaryNeuralstem beats Fresh Tracks Therapeutics on 7 of the 11 factors compared between the two stocks. Remove Ads Get Neuralstem News Delivered to You Automatically Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CUR vs. The Competition Export to ExcelMetricNeuralstemBiological Products, Except Diagnostic IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.43M$2.99B$5.63B$7.79BDividend YieldN/A1.55%5.37%4.04%P/E RatioN/A30.9323.6118.68Price / Sales5.50414.40373.3989.80Price / CashN/A168.6838.1734.64Price / Book0.103.766.734.12Net Income-$4.93M-$71.95M$3.20B$247.10M Neuralstem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CURNeuralstemN/A$0.68-1.1%N/A+72.6%$1.43M$260,000.000.006Gap DownFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+3.4%$5.59M$10.06M-0.6620ONVOOrganovo0.9924 of 5 stars$2.99-4.8%N/A-81.9%$5.09M$122,000.00-3.5220CELZCreative Medical Technology1.4012 of 5 stars$2.64-8.3%N/A-58.3%$4.62M$11,000.00-0.695High Trading VolumeTTNPTitan Pharmaceuticals1.5843 of 5 stars$4.14-1.2%N/A-50.7%$3.78M$180,000.00-0.7910Short Interest ↓Gap UpGENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050High Trading VolumeSCNIScinai Immunotherapeutics0.6279 of 5 stars$3.40flatN/A-48.2%$2.90M$452,000.00-0.0120CEROCERo TherapeuticsN/A$0.95+4.6%N/A-99.8%$2.75MN/A0.008News CoverageGap UpEVAXEvaxion Biotech A/S2.589 of 5 stars$1.85-2.1%$20.00+981.1%-88.4%$2.17M$3.30M-1.2860Earnings ReportNews CoveragePALIPalisade Bio2.3856 of 5 stars$0.70-1.4%$23.00+3,181.0%-88.6%$1.94M$250,000.00-0.0510WINTWindtree Therapeutics2.5215 of 5 stars$1.76+18.9%$350.00+19,786.4%-99.6%$1.32MN/A-0.1130Short Interest ↓Gap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies FRTX Alternatives ONVO Alternatives CELZ Alternatives TTNP Alternatives GENE Alternatives SCNI Alternatives CERO Alternatives EVAX Alternatives PALI Alternatives WINT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CUR) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuralstem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuralstem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CUR Stock Free CUR Stock Alerts